MedPath
HSA Approval

MYOLID CAPSULES 25 MG

SIN16952P

MYOLID CAPSULES 25 MG

MYOLID CAPSULES 25 MG

February 19, 2024

DKSH SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantDKSH SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

L04AX04

lenalidomide

Manufacturer Information

DKSH SINGAPORE PTE. LTD.

BIOCON PHARMA LIMITED

Active Ingredients

Lenalidomide

25mg

Proparacaine

Documents

Package Inserts

Myolid Capsule PI.pdf

Approved: February 19, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MYOLID CAPSULES 25 MG - HSA Approval | MedPath